Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comparative Study
. 2015 Mar;19(3):342-7.
doi: 10.1007/s12603-014-0561-x.

Comparisons of sarcopenia prevalence based on different diagnostic criteria in Chinese older adults

X Wen  1 , P An, W C Chen, Y Lv, Q Fu
Affiliations
Comparative Study

Comparisons of sarcopenia prevalence based on different diagnostic criteria in Chinese older adults

X Wen et al. J Nutr Health Aging. 2015 Mar.

Abstract

The study aimed to describe the prevalence of sarcopenia and discussed the applicability of different diagnostic criteria in Chinese older adults. 286 Chinese adults (136 men and 150 women) aged 60-88 were recruited. The prevalence of sarcopenia were calculated using different diagnostic criteria. Physical functioning was compared in sarcopenic and non-sarcopenic older adults. Compared with the standard of EWGSOP (European Working Group on Sarcopenia in Older People), the prevalence of sarcopenia was higher when the IWGS (International Working Group on Sarcopenia) standard was applied (Men: 7.4% vs. 0.8%; Women: 4.7% vs. 0%). If the AWGS (Aisa Working Group on Sarcopenia) standard was applied, the prevalence was 5.9% in men and 0.7% in women. In conclusion, the prevalence of sarcopenia in Chinese older adults ranged from 0% to around 10% when the diagnostic criteria of IGWS, EWGSOP and AGWS were applied. Further studies are still needed to investigate appropriate diagnostic criterion of sarcopenia for Chinese population.

PubMed Disclaimer

References

    1. Van Kan GA. Epidemiology and consequences of sarcopenia. J Nutr Health Aging. 2009;13:708–712. 10.1007/s12603-009-0201-z - DOI - PMC - PubMed
    1. Arango-Lopera VE, Arroyo P, Gutierrez-Robledo L, Perez-Zepeda MU, Cesari M. Mortality as an adverse outcome of sarcopenia. J Nutr Health Aging. 2013;17:259–262. 10.1007/s12603-012-0434-0 PubMed PMID: 23459979. - DOI - PMC - PubMed
    1. Bijlsma AY, Meskers CGM, Ling CHY, Narici M, Kurrle SE, Cameron ID, Westendorp RGJ, Maier AB. Defining sarcopenia: The impact of different diagnostic criteria on the prevalence of sarcopenia in a large middle aged cohort. AGE. 2012;35:871–881. 10.1007/s11357-012-9384-z PMCID 3636407. - DOI - PMC - PubMed
    1. Alexandre TS, Duarte YAO, Santos JLF, Wong R, Lebrao ML. Prevalence and associated factors of sarcopenia among elderly in brazil: Findings from the sabe study. J Nutr Health Aging. 2014;18:284–290. 10.1007/s12603-013-0413-0 - DOI - PubMed
    1. Lau EMC, Lynn HSH, Woo JW, Kwok TCY, Melton LJI. Prevalence of and risk factors for sarcopenia in elderly chinese men and women. J Gerontol A Biol Sci Med Sci. 2005;60:213–216. 10.1093/gerona/60.2.213 PubMed PMID: 15814865. - DOI - PubMed

Publication types